The global home infusion therapy market is expected to hit $26.7 billion by 2020, growing at a compound annual growth rate of 9 percent, according to a recent Persistence Market Research report. This year, the market is worth about $15.9 billion.

The main drivers behind the market are the rise in the elderly population, the mounting prevalence of chronic diseases, the growing home care market for infusion therapy, technological advances and the increasing usage of infusion pumps for pain management.

However, the patient safety issues revolving around infusion pumps due to errors and reimbursement issues are hindering the market's growth.

Some of the major trends in the market are the increasing acceptance of specialty infusion therapy, the rise in mergers and acquisitions, popularity of ambulatory infusion pumps and new product innovations.

Right now, North America makes up the largest portion of the global market because of the rising occurrence of chronic diseases and increasing health care costs. But Japan, China and Germany also make up a significant portion of the market.

Some of the big players in the market are Baxter International Inc., B. Braun Melsungen AG, Caesarea Medical Electronics, Fresenius Kabi AG, Smiths Medical, CareFusion Corp., ICU Medical, Inc., JMS Co., Ltd and Terumo Medical Corporation.